Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen

BACKGROUND: Raltegravir is the first integrase inhibitor approved for treatment of HIV-infected patients harboring multiresistant viruses. METHODS: From a Danish population-based nationwide cohort of HIV patients we identified the individuals who initiated a salvage regimen including raltegravir and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Engsig, Frederik N, Gerstoft, Jan, Kronborg, Gitte, Larsen, Carsten S, Pedersen, Gitte, Audelin, Anne M, Jørgensen, Louise B, Obel, Niels
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2010
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2943192/
https://ncbi.nlm.nih.gov/pubmed/20865112
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge